Publication | Closed Access

Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival

Cancer ImmunosurveillanceDifferential LevelsT-regulatory CellImmunologyRegulatory T CellsImmune Checkpoint InhibitorImmunotherapyMedicineCell BiologyTumor MicroenvironmentOvarian Cancer